Hibino Emi

ヒビノエミ | Hibino Emi

Affiliation and department：

Research field (2)： Pharmaceuticals - analytical and physicochemistry , Biophysics

Research keywords (5)： intrinsically disordered proteins , p53 , NMR , protein interaction , Alzheimer's disease

Research theme for competitive and other funds (15)：

Show all

Papers (16)：

Yuri Emoto, Ryoya Katayama, Emi Hibino, Sho Ishihara, Natsuko Goda, Takeshi Tenno, Yoshihiro Kobashigawa, Hiroshi Morioka, Hidekazu Hiroaki. A Cost-Effective Immobilization Method for MBP Fusion Proteins on Microtiter Plates Using a Gelatinized Starch-Agarose Mixture and Its Application for Convenient Protein-Protein Interaction Analysis. Methods and Protocols. 2023. 6. 3. 44-44
Yosuke Senju, Emi Hibino. Moesin-ezrin-radixin-like protein merlin: Its conserved and distinct functions from those of ERM proteins. Biochimica et biophysica acta. Biomembranes. 2022. 1865. 2. 184076-184076
Emi Hibino, Takeshi Tenno, Hidekazu Hiroaki. Relevance of Amorphous and Amyloid-Like Aggregates of the p53 Core Domain to Loss of its DNA-Binding Activity. Frontiers in Molecular Biosciences. 2022. 9. 869851-869851
Emi Hibino, Yusuke Ichiyama, Atsushi Tsukamura, Yosuke Senju, Takao Morimune, Masahito Ohji, Yoshihiro Maruo, Masaki Nishimura, Masaki Mori. Bex1 is essential for ciliogenesis and harbours biomolecular condensate-forming capacity. BMC Biology. 2022. 20. 1. 42-42
Koki Kataoka, Shota Suzuki, Takeshi Tenno, Natsuko Goda, Emi Hibino, Atsunori Oshima, Hidekazu Hiroaki. A cryptic phosphate-binding pocket on the SPFH domain of human stomatin that regulates a novel fibril-like self-assembly. Current research in structural biology. 2022. 4. 158-166

ｍore...

MISC (11)：

江本結理, 片山稜也, 合田名都子, 日比野絵美, 天野剛志, 小橋川敬博, 森岡弘志, 廣明秀一. タンパク質間相互作用解析を目的としたスターチ・アガロースゲルを用いたMBP融合タンパク質の固定化法. 日本蛋白質科学会年会プログラム・要旨集. 2023. 23rd (CD-ROM)
Cristobal Dos Remedios, Charles Cranfield, Donna Whelan, Charles Cox, Keith Shearwin, Joshua Ho, Toby Allen, Risa Shibuya, Emi Hibino, Kumiko Hayashi, et al. A special issue of the Australian society for Biophysics. Biophysical reviews. 2022. 14. 1. 1-2
Charles Cranfield, Donna Whelan, Charles Cox, Keith Shearwin, Joshua Ho, Toby Allen, Risa Shibuya, Emi Hibino, Kumiko Hayashi, Cristobal dos Remedios, et al. Announcing the call for the Special Issue on “The Australian Society for Biophysics (ASB) - 2021 Meeting”. Biophysical Reviews. 2021
中野将希, 三ツ石弥千代, 渡邊直希, 日比野絵美, 斉藤貴志, 西道隆臣, 鈴木利治, 西村正樹. 大脳皮質におけるILEI/FAM3CおよびAβの間質液への分泌様式に関する比較検討. Dementia Japan. 2019. 33. 4. 514-514
Emi Hibino. Physicochemical study on ILEI suppressing amyloid-β generation. KURNS Progress Report 2018. 2019

ｍore...

Patents (2)：

Lectures and oral presentations (26)：

p53およびSARS-CoV2における異常凝集体の分析
(第15回タンパク質の異常凝集とその防御・修復機構に関する研究会 2024)
SARS-CoV-2スパイクタンパク質由来断片のアミロイド線維形成
(第70回日本薬学会東海支部総会・大会 2024)
Preparation and analysis of aggregates formed by the tumor suppressor protein p53
(2023)
ANALYSIS AND COMPARISON OF AMORPHOUS & AMYLOID AGGREGATES OF THE TUMOR SUPPRESSOR P53.
(67th Biophysical Society Annual Meeting 2023)
CTCFによる転移因子コード解読機構解明に向けて
(第45回日本分子生物学会年会 2022)

ｍore...

Education (2)：

Professional career (1)：

Work history (4)：

2022/04 - 現在 Nagoya University Graduate School of Pharmaceutical Science
2020/06 - 現在 Shiga University of Medical Science Molecular Neuroscience Research Center
2020/06 - 2022/03 Nagoya University Graduate School of Pharmaceutical Science
2017/04 - 2020/05 Shiga University of Medical Science Molecular Neuroscience Research Center

Committee career (3)：

Awards (3)：

2024/06 - IUPAB2024 Student and Early Career Researcher Poster Award The function of multiple aggregates formed by the tumor suppressor protein p53
2024/01 - 愛知県若手研究者イノベーション創出奨励事業第18回わかしゃち奨励賞基礎研究部門優秀賞新規がん診断薬・治療薬開発を志向したp53凝集体分析法開発
2023/02 - Biophysical Society 2023 Travel Award

Association Membership(s) (5)：

THE JAPANESE BIOCHEMICAL SOCIETY , PROTEIN SCIENCE SOCIETY OF JAPAN , THE BIOPHYSICAL SOCIETY OF JAPAN , 日本分子生物学会 , 日本核磁気共鳴学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page